In contrast to immunity against some other facultative intracellular parasites, protective immunity against Brucella abortus is mediated in mice by antibodies as well as by cell-mediated immune responses. It was the purpose of this study to determine whether antibody alone would prevent infection with B. abortus. The majority (82%) of CD-1 outbred mice infected with 100 CFU of virulent B. abortus 2308 preincubated with graded quantities of an 0 polysaccharide-specific IgG2a monoclonal antibody (MAb) were free of infection 1, 2, 4, and 6 weeks later, based on detection limits of 13 brucellae per spleen and 39 per liver. Infection was present in 95% of control animals. Similar results were obtained with a challenge dose of 500 CFU, but with a challenge dose of 5,000 CFU, infection became established even with the highest concentration of MAb used (50 ,ug of MAb per 5,000 brucellae). Pretreatment with an 0 polysaccharide-specific IgGl MAb or with convalescent-phase serum diminished but did not prevent establishment of infection by 100 CFU of B. abortus. A majority of culture-negative mice tested 6 weeks after infection were serologically negative, which could have signified either the absence of previous infection or the early elimination of infection. In an in vitro test system, all of the antibody preparations were efficient in opsonizing B. abortus. Effective killing of the organism by unelicited mouse peritoneal macrophages occurred in conventional but not in endotoxin-free medium, suggesting that activated macrophages were required for killing of opsonized B. abortus. These results emphasize the potential importance of antibodies in the immunoprophylaxis of brucellosis and suggest that the design of a successful vaccine will require the induction of antibodies not only of appropriate specificity but also of the optimal isotype for mediating protective functions.
Although it has been demonstrated repeatedly in the murine model that passively administered antibody enhances protective immunity against the facultative intracellular bacterium Brucella abortus (1, 13-16, 19, 22, 26) , antibody titers induced by vaccines in cattle continue to be regarded as undesirable because they interfere with the interpretation of serodiagnostic tests. However, if it were possible to demonstrate that antibodies alone could not only diminish but also prevent the establishment of B. abortus infection in mice, there would be cause to examine more critically the role of humoral immunity in bovine brucellosis and perhaps to reevaluate some of the criteria placed on the composition of an ideal vaccine.
This study examined further the role of passive antibody in murine brucellosis. It was our intention to determine whether, under appropriate experimental conditions, antibody was capable of preventing infection with B. abortus. Monoclonal antibodies specific for the 0 polysaccharide were selected because such antibodies had been shown to enhance protection (13, 16) . In vitro phagocytosis and killing assays were performed with the same antibodies for comparison with the in vivo experiments. Functional comparisons were also made between the monoclonal antibodies and immune serum from convalescent mice.
MATERIALS AND METHODS
Mice. BALB/c ByJ mice were obtained from the Jackson Laboratory, Bar Harbor, Maine, and outbred CD-1 mice were obtained from Charles River Breeding Laboratories, Inc., Kingston, N.Y. Females were purchased at 9 weeks of age and kept for 1 week before use.
Bacterial strains. Virulent B. abortus 2308 was used in all experiments. For mouse challenge infections, frozen stock cultures of predetermined concentration were diluted directly to the desired level in phosphate-buffered saline (PBS) and injected intravenously. For in vitro challenge of murine macrophages, 2-day plate cultures were suspended in PBS and were adjusted turbidimetrically to the desired concentration (15) . Exact doses for in vivo and in vitro experiments were established retrospectively by plate counts (15) .
Antibodies for passive transfer. Two murine monoclonal antibodies (MAb) with specificity for the B. abortus 0 polysaccharide were used. An immunoglobulin G2a (IgG2a) MAb produced by clone 34 (16) was grown in tissue culture and had been freed of antibiotics by affinity chromatography and filter sterilized. It was held at 4°C at a final concentration of 2.67 mg/ml. Antibodies produced by clone 34 had been demonstrated previously to confer protection upon mice (16) . The antibodies were of high affinity (Ka = 7.6 x PBS, dialyzed in PBS for 24 h to remove NaN3, filter sterilized, and frozen in 1-ml aliquots at -70°C.
Polyclonal antiserum consisted of pooled sera from two mice which had been infected 9 (30) . Three prediluted standards were included on each plate and used to normalize readings for comparisons among plates.
Statistical methods. A mean value for each bacterial count was obtained by averaging the triplicate values following log conversion (15) . Liver counts were adjusted to account for culturing only the left lateral lobe, which made up one-third of the organ. Where required, sufficient quantities of tissue homogenates were plated to permit limits of detection estimated at 13 colonies per spleen and 39 colonies per liver. Thus, spleens and livers in which no colonies were detected in any of the triplicates were assigned numbers of 12 and 38, respectively. Statistical significance was determined by a one-way analysis of variance. Individual comparisons were made with paired one-way t tests (23) .
RESULTS
Passive protection experiments. Preliminary experiments in which B. abortus was opsonized with the IgGl MAb demonstrated that infection could be reduced but not prevented with the challenge dose (5 x 104 organisms) conventionally used in this laboratory (15, 16, 29, 30) . Lower challenge doses were therefore evaluated in BALB/c and CD-1 mice to determine the lowest dose which would establish a chronic infection. The level of the plateau phase decreased with lower challenge doses, and B. abortus grew to somewhat smaller numbers in spleens of CD-1 mice. Based on these results, most subsequent experiments were performed with an infection dose of 100 CFU in CD-1 mice. It must be emphasized that over the course of a year, a number of experiments that were initiated with this low infection dose showed unacceptably low levels of infection in a majority of control mice of a given shipment. This occurred with both strains of mice, despite procurement of mice from the same vendors, the use of the same stocks of bacteria for infection, and every effort to keep environmental conditions constant. Lot-to-lot variations in mice, resulting in variable responses to vaccination and challenge infections, have been noted previously (30) .
An initial trial with an infection dose of 100 CFU opsonized with three concentrations of the IgG2a MAb (50, 10, and 1 ,ug/100 pLA containing 100 CFU) demonstrated excellent protection at 1 and 2 weeks postinoculation (p.i.) (data not shown). This experiment was repeated and extended to a period of 6 weeks. Although 19 MAb. There were five mice per treatment group; bars indicate standard deviations. Dotted lines at log1o 1.59 and log1o 1.12 represent the limit of detection of organisms in the liver and spleen, respectively. weeks), only 11 of 60 antibody-treated mice (18%) had detectable infections in the liver or spleen (Fig. 1) . A mouse was considered infected if a single colony was isolated from either of the organs cultured (Fig. la) . There was no apparent difference among treatment groups in the total number of mice infected over the course of the experiment. Moreover, the numbers of organisms isolated from the antibodytreated, infected mice were extremely small ( Fig. lb and c) , and those isolated from the spleen were significantly smaller than those of the control groups at each time point (P < 0.05 to P < 0.001). In the liver differences were significant at 1 week p.i. (50-,ug group) and 4 weeks p.i. (all groups) (P < 0.05).
The effectiveness of the IgG2a MAb against higher infection doses (500 and 5,000 CFU) was evaluated at 1, 2, and 4 weeks p.i. by using the highest concentration of antibody (50 ,ug/100 ,ul containing 500 or 5,000 organisms, respectively) used in the previous experiment. At the lower infection dose, only 4 of the 15 antibody-treated mice (27%) were infected (Fig. 2a) . Detectable infections were restricted to the spleen (Fig. 2b and c) , in which the numbers of organisms cultured were extremely small and differed significantly from those in the control groups (spleen, P < 0.01 to P < 0.001). At a challenge dose of 5,000 CFU all mice were infected (Fig. 2d) , although in antibody-treated mice the numbers of brucellae recovered from the livers and spleens were significantly smaller (spleen, P < 0.001; liver P < 0.05 to P < 0.01) at each time point, and infections were nearly undetectable by 4 weeks p.i. (Fig. 2e and f) .
The IgGl MAb was evaluated in CD-1 mice by using three 10-fold dilutions of antibody (containing 10, 1, and 0.1 pl of reconstituted MAb per 100 .ld) and an infecting dose of 100 CFU. There was a significant reduction in spleen counts of antibody-treated mice in all three treatment groups at 1 week p.i. and in two of the three groups at 2 weeks p.i. (P < 0.01 to P < 0.001) ( Table 1) . However, the number of infected mice increased in each group from week 1 to week 2 p.i., and 14 of the 15 antibody-treated mice (93%) were infected by week 2 (Table 1 ).
An experiment of the same design was conducted with convalescent-phase serum from mice which had been infected with strain 19. CD-1 mice were injected with 100 brucellae which had been opsonized with antiserum in dilutions of 1:5, 1:50, or 1:500. At weeks 1 and 2 p.i., 29 of 30 mice (97%) given opsonized bacteria were infected, whereas at 4 and 6 weeks p.i., the number of infected mice in the treated groups had decreased to 5 of 30 (17%) and clearance was complete in the groups which had received cells opsonized with the intermediate dilution of antiserum (Fig. 3a) . Bacterial counts in the spleens of antibody-treated mice were significantly lower (P < 0.05 to P < 0.001) in all groups at all time points, with the exception of the group given the 1:500 dilution at 6 weeks p.i. (Fig. 3c) . In accord with prior observations (21) , liver counts of antibody-treated mice in two of three groups (1:5 and 1:500) were significantly higher than those of control groups at 1 week p.i. (P < 0.05), but counts of all treated groups were significantly lower (P < 0.05) at 4 weeks p.i. (Fig. 3b) . Antibody responses following infection. Antibody responses and spleen counts of individual mice infected 6 weeks previously with B. abortus pretreated with the IgG2a MAb or with polyclonal antiserum are presented in Tables 2  and 3 , respectively. Of 15 mice in each group infected with opsonized bacteria, 9 displayed antibody responses comparable to those in normal mice (slopes, <16). All of these were culture negative (Tables 2 and 3 ). The remaining 12 animals had moderate to high antibody responses in conjunction with culture-negative (10 mice) or culture-positive status (Tables  2 and 3 ). The antibody levels of the five mice treated with the 1:5 serum dilution were quite uniform and may have represented residual levels of transferred antibodies (Table 3) . Of 12 control mice, 11 were culture positive and all had moderate to high antibody responses. However, there was no consistent relationship between the numbers of brucellae in the spleen and the level of the antibody response (Tables 2  and 3) .
Opsonization and killing assays in vitro. Results of representative experiments are shown in Fig. 4 . Ingestion of B. abortus 2308 was negligible in the absence of antibodies but was effectively facilitated by both of the MAbs and by the polyclonal antiserum used in the passive-transfer experiments (Fig. 4) . The total number of brucellae ingested was related directly to the concentrations of bacteria and antibodies used and to the time permitted for phagocytosis (data not shown). A time of 15 min was selected for phagocytosis to prevent an underestimation of intracellular killing, because in conventional medium up to 30% of the ingested brucellae were killed within the first hour (data not shown). When concentrations of opsonizing antibodies were adjusted to permit an approximately equivalent uptake of B. abortus, bacterial killing in conventional medium was efficient and followed similar kinetics with all three preparations. By 4 h after phagocytosis, 90% or more of the ingested organisms had been killed (Fig. 4a) . In endotoxin-free medium, on the other hand, phagocytosis was uniformly diminished and the rates of killing were dramatically reduced, in particular following opsonization with whole serum when initial replication occurred (Fig. 4b) . DISCUSSION Although a number of earlier studies (1, 13-16, 19, 21, 26) , including one conducted with the IgG2a MAb produced by clone 34 (16) , have affirmed a protective role of antibodies against B. abortus in the murine model system, the data have demonstrated statistically significant reduction, rather than prevention, of infection. The present study was performed to determine whether antibodies could actually prevent the establishment of infection. Experimental conditions were set, on the one hand, to favor that outcome, and on the other, to provide as rigorous as possible a test of the question. Therefore, the infecting strain was preincubated with antibodies and the challenge dose was reduced in most experiments to one just large enough to establish a chronic infection. Concomitantly, we increased the sensitivity of our assay system 10-fold, so that "infection-free" status meant the presence of fewer than 13 brucellae in the entire spleen and fewer than 39 in the entire liver. Experiments were carried out for at least 4 and up to 6 weeks to ensure that animals judged free of infection at early intervals did not possess niduses of infection that would later produce detectable numbers of bacteria. The results of this study provide VOL. 57, 1989 (/3442 WINTER ET AL. 10. c_, s12 organisms per spleen. All mice with a culture-negative spleen also had a culture-negative liver. strong evidence that antibodies specific for the 0 polysaccharide can prevent the establishment of infection with B. abortus in a majority of normal mice, although success in this endeavor was limited to the IgG2a MAb (Fig. 1) . At 6 weeks p.i., antibody responses were negative in most mice treated with the IgG2a MAb, as well as in a majority of those infected with serum-opsonized bacteria (Table 2) . Since the latter group of mice would almost certainly have been culture positive at 1 and 2 weeks p.i. (Fig. 3a) , a negative antibody response at 6 weeks p.i. must be interpreted to signify either a lack of prior infection or the establishment of a transient infection which was eliminated by 6 weeks p.i. The possibility cannot be excluded that the passively transferred antibody itself inhibited the formation of antibody (17, 22, 27) . However, the fact that negative responses were more consistent in the group receiving a smaller quantity of MAb (10 ,ug) (Table 2) suggests that antibody-mediated immunosuppression was not the predominant factor.
Infection was prevented or rapidly terminated in the majority of mice (73%) given a challenge dose of 500 CFU preopsonized with 50 jig of the IgG2a MAb (Fig. 2a) , but all animals became infected when the dose was increased to 5,000 organisms (Fig. 2d) . This may have been due to an inadequate concentration of MAb, although with a challenge dose of 100 CFU there was no evidence for a dose-response effect with two of the three opsonins used, and the effectiveness of the intermediate concentrations of the IgG2a MAb ( Fig. 1; Table 2 ) and whole serum ( Fig. 3; Table 3 ) appeared to have equaled or exceeded that of the highest concentrations.
In contrast to the effects of the IgG2a MAb, opsonization (Fig. 3a) failed to prevent infection with B. abortus, although pretreatment with whole serum caused a markedly accelerated elimination of infection in most mice, which was evident at 4 and 6 weeks p.i. (Fig. 3a) . The basis for these differences has not yet been established. It should be emphasized that few direct comparisons among these preparations can be made in the concentrations, affinities, or fine specificities of the antibodies which they contained. Although all of the antibody preparations demonstrated opsonic activity in vivo, and killing of B. abortus followed similar kinetics in conventional medium (Fig. 4a) , it is still probable that the IgG2a MAb functioned more effectively in vivo. In mice, IgG2a antibodies bind to the high-affinity type 1 Fc receptor (28) and are active in complement fixation (11) . These (30) (Table 2) .
The in vitro assays were performed to ensure that each of the antibody preparations opsonized B. abortus and to determine whether virulent B. abortus would be killed within nonactivated macrophages in which cell function had been stimulated following Fc receptor binding (4, 8) . In accord with prior reports (8, 31) , phagocytosis of smooth B. abortus was negligible in the absence of opsonins (Fig. 4) . The data (Fig. 4) (25) . Since the 0 polysaccharide of B. abortus contains more than one epitope (3, 6) , one strategy might be a dissection of the epitopes into those which are essential for protection and those which are not. A vaccine could be constructed to incorporate only an essential epitope, thus allowing ready distinction of cattle which had been vaccinated from those responding to infection with field strains of B. abortus.
